PHILADELPHIA, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Puma Biotechnology, Inc. ("Puma") (NASDAQ: PBYI) on behalf of the company's shareholders. Click for additional information: https://kaskelalaw.com/case/puma-biotechnology/ Since February 2024, shares of Puma's stock have declined in value from a trading price of over $7.25 per share to a current trading price of less than $3.00 per share, a decline of over $4.25 per share, or over 58% in value. The investigati ...